NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (OTCBB: BONU), a specialty life science technology-based company, today announced that it has signed definitive financing and strategic distribution agreements, which will result in the assumption of, and indemnification for, $2.3 million in accounts payable and the assumption of, and indemnification for, $2 million in notes payable.
